Charles D Adams
Examiner (ID: 9396, Phone: (571)272-3938 , Office: P/2164 )
Most Active Art Unit | 2152 |
Art Unit(s) | 2164, 2152 |
Total Applications | 483 |
Issued Applications | 170 |
Pending Applications | 61 |
Abandoned Applications | 252 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 16977539
[patent_doc_number] => 20210221776
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-07-22
[patent_title] => PERFLUOROAMINOOLEFINS AND METHODS OF MAKING AND USING THE SAME
[patent_app_type] => utility
[patent_app_number] => 17/055498
[patent_app_country] => US
[patent_app_date] => 2019-05-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10792
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17055498
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/055498 | Perfluoroaminoolefins and methods of making and using the same | May 9, 2019 | Issued |
Array
(
[id] => 14777801
[patent_doc_number] => 20190263798
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-08-29
[patent_title] => NOVEL COMPOUNDS
[patent_app_type] => utility
[patent_app_number] => 16/407300
[patent_app_country] => US
[patent_app_date] => 2019-05-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16473
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -5
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16407300
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/407300 | NOVEL COMPOUNDS | May 8, 2019 | Abandoned |
Array
(
[id] => 14746629
[patent_doc_number] => 20190256488
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-08-22
[patent_title] => Facile and Selective Perfluoro- And Polyfluoroarylation of Meldrum's Acid
[patent_app_type] => utility
[patent_app_number] => 16/404110
[patent_app_country] => US
[patent_app_date] => 2019-05-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3532
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 87
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16404110
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/404110 | Facile and selective perfluoro- and polyfluoroarylation of Meldrum's acid | May 5, 2019 | Issued |
Array
(
[id] => 17228822
[patent_doc_number] => 20210355378
[patent_country] => US
[patent_kind] => A9
[patent_issue_date] => 2021-11-18
[patent_title] => HETEROCYCLIC COMPOUNDS EXHIBITING THERMALLY ACTIVATED DELAYED FLUORESCENCE (TADF) AND THEIR USE IN ELECTROLUMINESCENT DEVICES
[patent_app_type] => utility
[patent_app_number] => 17/049304
[patent_app_country] => US
[patent_app_date] => 2019-04-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12323
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -42
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17049304
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/049304 | HETEROCYCLIC COMPOUNDS EXHIBITING THERMALLY ACTIVATED DELAYED FLUORESCENCE (TADF) AND THEIR USE IN ELECTROLUMINESCENT DEVICES | Apr 22, 2019 | Pending |
Array
(
[id] => 17228822
[patent_doc_number] => 20210355378
[patent_country] => US
[patent_kind] => A9
[patent_issue_date] => 2021-11-18
[patent_title] => HETEROCYCLIC COMPOUNDS EXHIBITING THERMALLY ACTIVATED DELAYED FLUORESCENCE (TADF) AND THEIR USE IN ELECTROLUMINESCENT DEVICES
[patent_app_type] => utility
[patent_app_number] => 17/049304
[patent_app_country] => US
[patent_app_date] => 2019-04-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12323
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -42
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17049304
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/049304 | HETEROCYCLIC COMPOUNDS EXHIBITING THERMALLY ACTIVATED DELAYED FLUORESCENCE (TADF) AND THEIR USE IN ELECTROLUMINESCENT DEVICES | Apr 22, 2019 | Pending |
Array
(
[id] => 18202342
[patent_doc_number] => 11584724
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-02-21
[patent_title] => Process for synthesis of a phenoxy diaminopyrimidine compound
[patent_app_type] => utility
[patent_app_number] => 17/048833
[patent_app_country] => US
[patent_app_date] => 2019-04-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 11
[patent_no_of_words] => 5772
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17048833
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/048833 | Process for synthesis of a phenoxy diaminopyrimidine compound | Apr 17, 2019 | Issued |
Array
(
[id] => 14684899
[patent_doc_number] => 20190241564
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-08-08
[patent_title] => 2-(HET)ARYL-SUBSTITUTED CONDENSED BICYCLIC HETEROCYCLE DERIVATIVES AS PEST CONTROL AGENTS
[patent_app_type] => utility
[patent_app_number] => 16/385249
[patent_app_country] => US
[patent_app_date] => 2019-04-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 34096
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -2
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16385249
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/385249 | 2-(het)aryl-substituted condensed bicyclic heterocycle derivatives as pest control agents | Apr 15, 2019 | Issued |
Array
(
[id] => 15866043
[patent_doc_number] => 20200140425
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-05-07
[patent_title] => COMPOUNDS FOR THE TREATMENT OF TUBERCULOSIS
[patent_app_type] => utility
[patent_app_number] => 16/380116
[patent_app_country] => US
[patent_app_date] => 2019-04-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14754
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16380116
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/380116 | COMPOUNDS FOR THE TREATMENT OF TUBERCULOSIS | Apr 9, 2019 | Abandoned |
Array
(
[id] => 14652589
[patent_doc_number] => 20190233423
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-08-01
[patent_title] => POLYMORPHS
[patent_app_type] => utility
[patent_app_number] => 16/373971
[patent_app_country] => US
[patent_app_date] => 2019-04-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2564
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -3
[patent_words_short_claim] => 83
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16373971
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/373971 | POLYMORPHS | Apr 2, 2019 | Abandoned |
Array
(
[id] => 16762278
[patent_doc_number] => 20210107859
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-04-15
[patent_title] => A PROCESS FOR THE SYNTHESIS OF CARBON LABELED ORGANIC COMPOUNDS
[patent_app_type] => utility
[patent_app_number] => 17/044774
[patent_app_country] => US
[patent_app_date] => 2019-04-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18964
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 772
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17044774
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/044774 | A PROCESS FOR THE SYNTHESIS OF CARBON LABELED ORGANIC COMPOUNDS | Apr 2, 2019 | Abandoned |
Array
(
[id] => 16800165
[patent_doc_number] => 10995086
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-05-04
[patent_title] => Triazolone derivatives or salts thereof and pharmaceutical compositions comprising the same
[patent_app_type] => utility
[patent_app_number] => 16/359985
[patent_app_country] => US
[patent_app_date] => 2019-03-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 48356
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 39
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16359985
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/359985 | Triazolone derivatives or salts thereof and pharmaceutical compositions comprising the same | Mar 19, 2019 | Issued |
Array
(
[id] => 16541215
[patent_doc_number] => 20200407628
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-12-31
[patent_title] => COLOR MATCHED AND BRIGHT FLUORESCENT MATERIALS COMPOSED OF SMALL-MOLECULE IONIC LATTICES
[patent_app_type] => utility
[patent_app_number] => 16/762628
[patent_app_country] => US
[patent_app_date] => 2019-03-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12486
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -62
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16762628
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/762628 | COLOR MATCHED AND BRIGHT FLUORESCENT MATERIALS COMPOSED OF SMALL-MOLECULE IONIC LATTICES | Mar 9, 2019 | Pending |
Array
(
[id] => 17178316
[patent_doc_number] => 11155550
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-10-26
[patent_title] => Histone deacetylase inhibitors and methods of use thereof
[patent_app_type] => utility
[patent_app_number] => 16/290174
[patent_app_country] => US
[patent_app_date] => 2019-03-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 22979
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 629
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16290174
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/290174 | Histone deacetylase inhibitors and methods of use thereof | Feb 28, 2019 | Issued |
Array
(
[id] => 14808247
[patent_doc_number] => 20190270733
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-09-05
[patent_title] => Quinoline and Isoquinoline Based HDAC Inhibitors and Methods of Use Thereof
[patent_app_type] => utility
[patent_app_number] => 16/290136
[patent_app_country] => US
[patent_app_date] => 2019-03-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17566
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 284
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16290136
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/290136 | Quinoline and Isoquinoline Based HDAC Inhibitors and Methods of Use Thereof | Feb 28, 2019 | Abandoned |
Array
(
[id] => 16605891
[patent_doc_number] => 10906883
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-02-02
[patent_title] => Process-scale synthesis of urolithin A
[patent_app_type] => utility
[patent_app_number] => 16/287347
[patent_app_country] => US
[patent_app_date] => 2019-02-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 8054
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 73
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16287347
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/287347 | Process-scale synthesis of urolithin A | Feb 26, 2019 | Issued |
Array
(
[id] => 14777735
[patent_doc_number] => 20190263765
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-08-29
[patent_title] => SYNERGISTIC ANTICOAGULANT COMPOSITION
[patent_app_type] => utility
[patent_app_number] => 16/282941
[patent_app_country] => US
[patent_app_date] => 2019-02-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2691
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 333
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16282941
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/282941 | SYNERGISTIC ANTICOAGULANT COMPOSITION | Feb 21, 2019 | Abandoned |
Array
(
[id] => 18504590
[patent_doc_number] => 11702394
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-07-18
[patent_title] => Inhibitors of phospholipid synthesis and methods of use
[patent_app_type] => utility
[patent_app_number] => 16/968836
[patent_app_country] => US
[patent_app_date] => 2019-02-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 12
[patent_no_of_words] => 14630
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 47
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16968836
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/968836 | Inhibitors of phospholipid synthesis and methods of use | Feb 21, 2019 | Issued |
Array
(
[id] => 16719994
[patent_doc_number] => 20210087141
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-03-25
[patent_title] => COMPOUNDS HAVING S1P5 RECEPTOR AGONISTIC ACTIVITY
[patent_app_type] => utility
[patent_app_number] => 16/970865
[patent_app_country] => US
[patent_app_date] => 2019-02-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25500
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 449
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16970865
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/970865 | Compounds having S1P5 receptor agonistic activity | Feb 20, 2019 | Issued |
Array
(
[id] => 16970456
[patent_doc_number] => 11066417
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-07-20
[patent_title] => Modulators of cystic fibrosis transmembrane conductance regulator, pharmaceutical compositions, methods of treatment, and process for making the modulators
[patent_app_type] => utility
[patent_app_number] => 16/276350
[patent_app_country] => US
[patent_app_date] => 2019-02-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 43
[patent_figures_cnt] => 2
[patent_no_of_words] => 222256
[patent_no_of_claims] => 47
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16276350
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/276350 | Modulators of cystic fibrosis transmembrane conductance regulator, pharmaceutical compositions, methods of treatment, and process for making the modulators | Feb 13, 2019 | Issued |
Array
(
[id] => 16570543
[patent_doc_number] => 20210009549
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-01-14
[patent_title] => CANNABINOID DERIVATIVES AND CONJUGATES AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/969942
[patent_app_country] => US
[patent_app_date] => 2019-02-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10321
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16969942
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/969942 | CANNABINOID DERIVATIVES AND CONJUGATES AND USES THEREOF | Feb 12, 2019 | Abandoned |